Biomedical Approaches to HIV Prevention

People who use and abuse alcohol and other drugs are an important population to target for HIV prevention because they are more likely to engage in sexual behaviors that increase their likelihood of acquiring or transmitting HIV. A variety of biomedical approaches to HIV prevention have been evaluated or currently are being studied. These approaches include an anti-HIV vaccine; topical protection treatments; and additional biomedical and barrier approaches, such as controlling sexually transmitted diseases, male circumcision, diaphragm use, and substance abuse treatment. The article also reviews topical versus oral antiretrovirals to prevent HIV transmission, antiretroviral treatment as prevention, and the role of alcohol and other drug use in HIV prevention.

• Publication year

  2010

• Venue

  Alcohol Research and Health

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 23584061PMCID 3860504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

  2010cited by this paper
• MORBIDITY AND MORTALITY

  2010cited by this paper
• Voluntary universal testing and treatment is unlikely to lead to HIV elimination: a modeling analysis

  2009cited by this paper
• Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders

  2009cited by this paper
• Prevalence and Clinical Implications of Interactive Toxicity Beliefs Regarding Mixing Alcohol and Antiretroviral Therapies among People Living with HIV/AIDS

  2009cited by this paper
• HIV Prevention: A Comprehensive Approach

  2009cited by this paper
• Injection drug use and HIV: past and future considerations for HIV prevention and interventions

  2009cited by this paper
• Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

  2009cited by this paper
• HIV risk and prevention for non-injection substance users

  2009cited by this paper
• Preexposure Antiretroviral Prophylaxis Attitudes in High-Risk Boston Area Men Who Report Having Sex With Men: Limited Knowledge and Experience but Potential for Increased Utilization After Education

  2009cited by this paper
• Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model.

  2009cited by this paper
• Risk-factors for non-adherence to antiretroviral therapy.

  2009cited by this paper
• The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

  2008cited by this paper
• Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression

  2008cited by this paper
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial.

  2008cited by this paper
• Illicit drugs, alcohol, and addiction in human immunodeficiency virus.

  2007cited by this paper
• Quantification of antiretroviral drugs for HIV‐1 in the male genital tract: current data, limitations and implications for laboratory analysis

  2007cited by this paper
• Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.

  2007cited by this paper
• Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.

  2007cited by this paper
• HIV/AIDS Risk Reduction Counseling for Alcohol Using Sexually Transmitted Infections Clinic Patients in Cape Town, South Africa

  2007cited by this paper
• Tenofovir Disoproxil Fumarate for Prevention of HIV Infection in Women: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

  2007cited by this paper
• Methamphetamine Use and Sexual Risk Behaviors in U.S. High School Students: Findings from a National Risk Behavior Survey

  2007cited by this paper
• Alcohol use, partner type, and risky sexual behavior among college students: Findings from an event-level study.

  2007cited by this paper
• Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial.

  2007cited by this paper
• Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women

  2006cited by this paper
• Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda

  2006cited by this paper
• Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.

  2006cited by this paper
• Expanding Research on the Role of Alcohol Consumption and Related Risks in the Prevention and Treatment of HIV_AIDS

  2006cited by this paper
• Microbicides: a new frontier in HIV prevention.

  2006cited by this paper
• Preexposure prophylaxis for HIV: unproven promise and potential pitfalls.

  2006cited by this paper
• Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model.

  2006cited by this paper
• Increased Risk of Incident HIV During Pregnancy in Rakai, Uganda: A Prospective Study

  2006cited by this paper
• Randomized, Controlled Intervention Trial of Male Circumcision for Reduction of HIV Infection Risk: The ANRS 1265 Trial

  2005cited by this paper
• In Vitro and In Vivo: The Story of Nonoxynol 9

  2005cited by this paper
• Early alcohol initiation and subsequent sexual and alcohol risk behaviors among urban youths.

  2005cited by this paper
• HIV-Inducing Factor in Cervicovaginal Secretions Is Associated With Bacterial Vaginosis in HIV-1-Infected Women

  2005cited by this paper
• Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

  2005cited by this paper
• Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study.

  2005cited by this paper
• Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

  2005cited by this paper
• Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV

  2005cited by this paper
• HIV Prevention with Drug-Using Populations Current Status and Future Prospects: Introduction and Overview

  2005cited by this paper
• Two drugs or three? Balancing efficacy, toxicity, and resistance in postexposure prophylaxis for occupational exposure to HIV.

  2004cited by this paper
• HIV and sexually transmitted diseases: lethal synergy.

  2004cited by this paper
• Substance use and sexual risk: a participant- and episode-level analysis among a cohort of men who have sex with men.

  2004cited by this paper
• Use of postexposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior

  2004cited by this paper
• Behavioral Impact, Acceptability, and HIV Incidence Among Homosexual Men With Access to Postexposure Chemoprophylaxis for HIV

  2004cited by this paper
• Antibody neutralization and escape by HIV-1

  2003cited by this paper
• EFFECTIVENESS OF COL-1492, A NONOXYNOL-9 VAGINAL GEL, ON HIV-1 TRANSMISSION IN FEMALE SEX WORKERS: A RANDOMISED, CONTROLLED TRIAL

  2003cited by this paper
• Inhibiting sexual transmission of HIV-1 infection

  2003cited by this paper
• Adolescent drinking and sex: findings from a daily diary study.

  2003cited by this paper
• HIV incidence on the increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using a novel approach for detecting recent infections

  2002cited by this paper
• Interactions between Recreational Drugs and Antiretroviral Agents

  2002cited by this paper
• Use of antiretroviral drugs to prevent sexual transmission of HIV.

  2002cited by this paper
• Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial.

  2002cited by this paper
• Certification of poliomyelitis eradication--Western Pacific Region, October 2000.

  2001cited by this paper
• New insights into host factors in HIV-1 pathogenesis.

  2001cited by this paper
• Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.

  2001cited by this paper
• Virologic and Immunologic Determinants of Heterosexual Transmission of Human Immunodeficiency Virus Type 1 in Africa

  2001cited by this paper
• Problem drinking and medication adherence among persons with HIV infection

  2001cited by this paper
• MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men.

  2000cited by this paper
• Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

  2000cited by this paper
• Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group.

  1999cited by this paper
• Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

  1998cited by this paper
• Effectiveness of Postinoculation (R)-9-(2-Phosphonylmethoxypropyl)Adenine Treatment for Prevention of Persistent Simian Immunodeficiency Virus SIVmne Infection Depends Critically on Timing of Initiation and Duration of Treatment

  1998cited by this paper
• A Case-Control Study of HIV Seroconversion in Health Care Workers After Percutaneous Exposure

  1998cited by this paper
• HIV prevention with drug-using populations--current status and future prospects: introduction and overview.

  1998cited by this paper
• A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

  1997cited by this paper
• Ethnic differences in the association between behavior with a new partner: an event-based analysis.

  1997cited by this paper
• Sexual transmission of HIV.

  1997cited by this paper
• Increased in Vitro Tetanus-Induced Production of HIV Type 1 Following in Vivo Immunization of HIV Type 1-Infected Individuals with Tetanus Toxoid

  1997cited by this paper
• "Impact of Improved Treatment of Sexually Transmitted Diseases on HIV Infection in Rural Tanzania: Randomised Controlled Trial."

  1996cited by this paper
• Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial.

  1995cited by this paper
• Prevention of SIV Infection in Macaques by (R)-9-(2-Phosphonylmethoxypropyl)adenine

  1995cited by this paper
• "Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type I with Zidovudine Treatment."

  1994cited by this paper
• Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual Transmission.

  1994cited by this paper
• Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

  1994cited by this paper
• White blood cells and HIV-1 in semen from vasectomised seropositive men.

  1991cited by this paper
• HIV prevention: the need for methods women can use.

  1990cited by this paper
• Acquired immune deficiency syndrome. Ocular manifestations.

  1983cited by this paper
• Morbidity and Mortality

  1981cited by this paper

• Exploring Pre-Exposure Prophylaxis (PrEP) and Post-Exposure Prophylaxis (PEP) Knowledge in Incarcerated Men

  2022cites this paper
• Structural Issues Associated with Pre-exposure Prophylaxis Use in Men Who Have Sex with Men

  2021cites this paper
• IMPLEMENTASI KEBIJAKAN PENCEGAHAN HIV/AIDS DI PROVINSI DKI JAKARTA

  2020cites this paper
• Transcending GIPA : towards an Ubuntu framework for mainstreaming participation of South African people living with HIV (PLHIV) in social change communication for HIV prevention.

  2015cites this paper
• An evaluation of the level of awareness about biomedical intervention for HIV prevention among the post secondary school youth in Richards Bay

  2014cites this paper
• HIV Discourse and Prevention Practices: A Case Study of Professional and Entrepreneurial Women in Dar Es Salaam, Tanzania

  2014cites this paper
• Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

  2013cites this paper
• eHealth interventions for HIV prevention

  2012cites this paper
• Pastoral care as community care : towards an intergrative approach to healing and well-being within the HIV and AIDS discourse

  2012cites this paper
• HIV/AIDS prevention policy processes in faith-based non-governmental organizations in Tanzania

  2011cites this paper